Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Inventory (2023 - 2026)

BioScience Health Innovations has reported Inventory over the past 4 years, most recently at $874340.0 for Q1 2026.

  • Quarterly Inventory rose 305.36% to $874340.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $874340.0 through Mar 2026, up 305.36% year-over-year, with the annual reading at $336348.0 for FY2025, 476.74% up from the prior year.
  • Inventory was $874340.0 for Q1 2026 at BioScience Health Innovations, up from $336348.0 in the prior quarter.
  • Over five years, Inventory peaked at $874340.0 in Q1 2026 and troughed at $14063.0 in Q1 2023.
  • The 4-year median for Inventory is $42225.0 (2024), against an average of $208913.3.
  • Year-over-year, Inventory grew 23.12% in 2024 and then surged 1693.96% in 2025.
  • A 4-year view of Inventory shows it stood at $37702.0 in 2023, then skyrocketed by 54.68% to $58319.0 in 2024, then surged by 476.74% to $336348.0 in 2025, then surged by 159.95% to $874340.0 in 2026.
  • Per Business Quant, the three most recent readings for BHIC's Inventory are $874340.0 (Q1 2026), $336348.0 (Q4 2025), and $757500.0 (Q3 2025).